What is Serimmune?
Serimmune operates at the forefront of immune intelligence, specializing in the decoding of human antibody responses. The company's proprietary platform is instrumental in facilitating research biomarker discovery projects. Recently integrated into Infinity Bio, Inc., Serimmune is poised to leverage advanced technologies in antibody reactome services to accelerate progress in immunology research and translational science. This strategic alignment aims to enhance scientific innovation and support for its clients, while Serimmune continues to offer its powerful short epitope profiling and discovery platform with expanded resources.
How much funding has Serimmune raised?
Serimmune has raised a total of $10.5M across 2 funding rounds:
Private Equity
$2.5M
Private Equity
$8M
Private Equity (2016): $2.5M, investors not publicly disclosed
Private Equity (2017): $8M led by Merck and Illumina Ventures
Key Investors in Serimmune
Merck
Merck, a global healthcare company founded in 1891, delivers innovative solutions through prescription medicines, biologic therapies, vaccines, and animal health products, indicating a strong interest in established pharmaceutical and health-related ventures.
Illumina Ventures
Illumina Ventures is a leader in genomics and precision health investing, focused on building an ecosystem that translates investment into innovation to enhance human health, suggesting a strategic focus on companies advancing life science research and biopharmaceutical drug development.
What's next for Serimmune?
The recent major strategic investment signifies a pivotal moment for Serimmune, positioning it for accelerated growth and expanded capabilities within the broader Infinity Bio, Inc. ecosystem. This capital infusion is expected to fuel further development of its immune intelligence platform and enhance its capacity for biomarker discovery. The company's focus on antibody reactome services, combined with its new resources, suggests a strategic push towards deeper insights in immunology and translational science, potentially leading to novel therapeutic targets and diagnostic tools.
See full Serimmune company page
